Antifungal treatment for oral candidiasis
DOI:
https://doi.org/10.59471/ijhsc2025258Keywords:
Candida, Emerging Pathogens, Antifungal Drugs, Antifungal TreatmentsAbstract
Introduction: the use of antifungal and/or fungistatic drugs of the azole or echinocandin type has decreased its effectiveness due to the mutagenic capacity of the Candida species.
Objective: to characterize aspects related to the antifungal treatment and resistance of oral candidiasis.
Method: a bibliographic search of articles published during the last 10 years will be carried out in the PubMed, Scielo and Google Scholar databases; in the English and Spanish languages. The selection of the works was carried out from the title and the abstract in a first instance, by a single operator.
Results: adding the articles searched with the key words, 5,501 articles were obtained in the three different databases. Based on the title of each article, 5,400 studies were excluded for not being in accordance with the inclusion criteria. 51 articles were eliminated after reading the abstract. In the complete reading of 50 articles, 30 works were chosen.
Conclusions: the search for an ideal antifungal agent remains a challenge as resistance to these treatments has developed, such that no antifungal agent currently meets all the requirements of an ideal drug for the treatment of Candida.
References
Negroni M. Microbiología estomatológica. Fundamentos y guía práctica. BOOKS 2010. https://books.google.com.cu/books?hl=es&lr=&id=Gxmui-vjZBgC&oi=fnd&pg=PA1&dq=1-%09Negroni,+M.+Microbiolog%C3%ADa+estomatol%C3%B3gica.+Fundamentos+y+gu%C3%ADa+pr%C3%A1ctica.+Argentina&ots=QoHDlDF5kQ&sig=j0UQVHr0NoYIcZJ97jyvezH1kRU&redir_esc=y#v=onepage&q=1-%09Negroni%2C%20M.%20Microbiolog%C3%ADa%20estomatol%C3%B3gica.%20Fundamentos%20y%20gu%C3%ADa%20pr%C3%A1ctica.%20Argentina&f=false.
Riera F. Asociación Panamericana de Infectología. Infecciones fúngicas sistémicas : manual práctico.3a edición bilingüe. ApiInfectologia 2019. https://apiinfectologia.org/wp-content/uploads/2023/11/MANUAL-MICOSIS.pdf.
Muñoz del Valle G. Candida glabrata Un patógeno emergente. Dialnet 2015;10. https://dialnet.unirioja.es/servlet/articulo?codigo=5460373.
Salazar Vásquez M, Sacsaquispe Contreras S. Presencia de hifas de cándida en adultos con mucosa oral clínicamente saludable. Revista Estomatológica Herediana 2005. https://doi.org/file:///C:/Users/Alex/Documents/Downloads/ojsadm,+1978-3739-1-CE%20(1).pdf.
Navarrete Cuadrado K, Estrada J, Salinas H, Bolaño Cervantes M. Infección nosocomial por Candida haemulonii en un lactante mayor. Dialnet 2020;15. https://dialnet.unirioja.es/servlet/articulo?codigo=8456850.
Muthular M, Passero P, Bálsamo F. Efecto inhibitorio Efecto inhibitorio del dietilestilbestrol sobre aislamientos clínicos de Candida albicans sensibles y resistentes a los azoles. Revista Iberoamericana de Micologia 2019;36. https://www.sciencedirect.com/science/article/abs/pii/S1130140619300312.
Bravo J. Candida haemulonii: causa infrecuente de peritonitis asociada a diálisis peritoneal. Revista Infection 2018;22. http://www.scielo.org.co/scielo.php?pid=S0123-93922018000100058&script=sci_arttext.
Santo Guanoluisa JM, Ron Mora ÁS. Bacterial resistance of microbial agents causing urinary tract infections in pregnant women. Salud, Ciencia y Tecnología 2024;4:728. https://doi.org/10.56294/saludcyt2024728.
González Salas R, Vidal Del Río MM, Medina Valencia MP, Jaramillo López MG. Bibliographic review on hepatopancreatic microsporidiosis in white shrimp penaeus vannamei: a current emerging disease. Salud, Ciencia y Tecnología 2023;3:601. https://doi.org/10.56294/saludcyt2023601.
Peláez Yáñez LA, Orraca Castillo O, García García M, Lugo Hernández A, Lorenzo Rodriguez MA, Vitón Castillo AA. Chronic mucocutaneous candidiasis: case report. Salud, Ciencia y Tecnología 2024;4. https://doi.org/10.56294/saludcyt2024.1368.
Aguiar Muñoz NR, Yauli Flores CF. Current Perspectives on Antifungal Resistance: Focus on Opportunistic Mycoses. Salud, Ciencia y Tecnología 2024;4:1064. https://doi.org/10.56294/saludcyt20241064.
Rodríguez Plasencia A, Ortiz Vásquez GE, Donoso Noroña RF, Gómez Martínez N. Impact of antimicrobial resistance in critically ill patients in the intensive care unit. Salud, Ciencia y Tecnología 2023;3:648. https://doi.org/10.56294/saludcyt2023648.
Zambrano Zambrano DT, Tabares Rosero LG. Influence of the use of psychotropic drugs on the increase of Escherichia coli resistance. Salud, Ciencia y Tecnología 2024;4:701. https://doi.org/10.56294/saludcyt2024701.
Pristov K, Ghannoum M. Resistance of Candida to azoles and echinocandins worldwide. Science Direct 2019;25. https://www.sciencedirect.com/science/article/pii/S1198743X19301491.
Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Online Librery 2013. https://onlinelibrary.wiley.com/doi/full/10.1155/2013/204237.
López-Ávila K, Dzul-Rosado K, Lugo-Caballero C. Mecanismos de resistencia antifúngica de los azoles en Candida albicans. Una revisión. Scielo 2016;27. https://www.scielo.org.mx/pdf/revbiomed/v27n3/2007-8447-revbiomed-27-03-127.pdf.
Du H, Bing J, Hu T, Ennis C, Nobile C. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog 2020;16. https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008921.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Marcia Godoy, María Isabel Brusca (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
How to Cite
